Hospira Vincristine Sulphate 5 mg/5 mL Injection vial (preserved)

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

下载 公众评估报告 (PAR)
28-11-2017

有效成分:

vincristine sulfate, Quantity: 1 mg/mL

可用日期:

Hospira Australia Pty Ltd

INN(国际名称):

Vincristine sulfate

药物剂型:

Injection, solution

组成:

Excipient Ingredients: benzyl alcohol; mannitol; water for injections

给药途径:

Intravenous

每包单位数:

5 x 5 mL pack

类:

Medicine Listed (Export Only)

处方类型:

(S1) This Schedule is intentionally blank

疗效迹象:

Vincristine Sulphate Injection is used in the treatment of cancers of the blood (eg. leukaemia or lymphomas), breast, head and neck or lung. It may be used to treat multiple myeloma (a cancer of plasma cells) and it may also be used in the treatment of some cancers in children. It may be used in a blood disorder known as idiopathic thrombocytopenic purpura (ITP) after other treatments have not been successful. Vincristine Sulphate Injection may be given alone or in combination with other anti-cancer medicines.

產品總結:

Visual Identification: A clear colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

授权状态:

Licence status A

授权日期:

2011-11-02